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Cloned mammals have bred
naturally for the first time,
researchers reported last month,
but faced the most trying of
times. Two endangered African
wildcat clones have each given
birth to a litter, a total of eight
kittens in all. The first five kittens
were born on July 26 to Madge,
a clone of the wildcat Nancy. The
second litter, consisting of three
kittens, was born on August 2 to
Caty, also a clone of Nancy. The
father of both litters is Ditteaux, a
clone of the African wildcat Jazz,
who made headlines when he
was born as the result of the
transfer of cryopreserved
embryos to a domestic cat.
“By improving the cloning
process and then encouraging
cloned animals to breed and
make babies we can revive the
genes of individuals who might
not be reproductively viable
otherwise, and we can save
genes from animals in the wild,”
said Betsy Dresser, director of
the Audubon Center for
Research of Endangered
Species, where they were born.
She said skin samples of a
long-dead but genetically
valuable animal, if properly
preserved, could be cloned to
create a genetic match of the
animal. These genes could then
be introduced back into the
population through natural
breeding. 
“The goal is to use whatever
tools we can to help boost these
populations,” she said.
But the Audubon Center is in
New Orleans and the
announcement was made 10
days before Hurricane Katrina
struck and at the time of going
to press there was no news on
how the center had fared.
Copy cats go natural 
Kitten issues: Researchers announced the birth of African wildcats from cloned
parents in New Orleans, days before the hurricane struck. (Photo: Audubon Center.)
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The human nervous system is an
extraordinarily complex structure,
and the things that we value most
in life, such as cognition and
being able to sense and interact
with the external world, depend
upon its proper wiring. Neurons
transmit information along their
axons, elongated processes
analogous to cables, which
connect their cell bodies to target
cells. The nervous system can be
divided into two distinct divisions,
the central nervous system (CNS),
which comprises the brain and
spinal cord, and the peripheral
nervous system (PNS), which
consists of the peripheral nerves
that innervate the body. One of
the ways in which these two
compartments of the nervous
system markedly differ lies in their
capacity to regenerate after injury.
In stark contrast to the PNS,
where severed axons often will
heal and successfully navigate
back to their original targets,
injured CNS neurons exhibit a
burst of stymied growth but
ultimately fail, with their axons
stalling out and forming distinctive
large endings dubbed ‘retraction
bulbs’ that fail to transverse the
site of injury (Figure 1). These
morphological changes are
thought to reflect regeneration
failure. Although axotomy can
cause neuronal death, many
neurons will survive months to
years after injury, particularly if
their axons have been severed far
from their cell bodies.
Clinically, the CNS’s inability to
re-wire after injury is exemplified
by patients who have suffered a
spinal cord injury. Although
damage to the spinal cord causes
general trauma, killing neurons
and supporting glial cells at the
site of injury, this disorder can be
viewed as primarily a re-wiring
problem as most pathological
symptoms, including numbness
and paralysis, reflect the
permanent interruption of the flow
of information from ascending
sensory and descending motor
tracts. Injuries to the lower spinal
segments generally render
patients unable to walk or control
their bladder and bowels, while
injuries to the cervical levels of the
spinal cord can cause additional
deficits including the loss of arm
movement and an inability to
breathe without a respirator. In
addition to obvious quality-of-life
concerns, the CNS’s failure to
rewire has enormous clinical
ramifications for such patients, as
reduced mobility often
precipitates fatal complications
including pneumonia, pulmonary
emboli and septicemia.
Current therapies aim to save
remaining intact fibers by
minimizing secondary damage.
The standard treatment often
involves stabilization of the spine
and administration of
methylprednisolone, a steroidal
drug that minimizes inflammation
and may decrease the number of
neurons that die as a result of
swelling. After this initial
pharmacological intervention,
treatment is limited to physical
therapy or, more rarely,
experimental stem cell
transplants. There is great
optimism in the field that
understanding more about the
molecular mechanisms that
prevent CNS regeneration will
spur targeted therapies that will
shift treatment goals from
palliative care to regeneration and
restoration of function after injury.
Reasons for optimism
Why do many scientists believe
that, with appropriate intervention,
CNS neurons would be capable of
regeneration? One could easily
imagine that central neurons are
simply hard-wired in such a way
that they will not repair under any
circumstance. Several lines of
evidence argue against this
possibility. First, as touched upon
earlier, axons in the PNS are
capable of regenerating after
injury. This is an interesting
phenomenon, as many neurons
with processes inside the PNS
also have an axon or part of an
axon within the CNS, yet only the
peripheral portions are able to
regenerate. These paradoxical
growth responses suggest that
the neurons’ interactions with the
two different environments may
contribute to their dissimilar
regenerative responses and that
the PNS, but not the CNS,
environment is a permissive
substrate for regenerative
outgrowth.
Furthermore, numerous
comparative studies have
revealed phylogenetic differences
in the capacity of different species
to regenerate. Whereas axons in
the CNS of warm-blooded
vertebrates (mammals and birds)
do not regenerate, those in many
lower vertebrates, including newts
and salamanders, can regenerate
after injury. Very young mammals,
birds and certain amphibians are
also often capable of substantial
CNS repair [1]. These data
suggest that the lack of CNS
regeneration in vertebrates is the
result of a recent evolutionary
change, although it is still unclear
whether these varied responses
are caused by differences in
expression of genes that are
conserved across these
organisms or by the presence of
proteins specific to warm-blooded
vertebrates.
Although one hesitates to draw
too many conclusions from these
disparate data, observations of
robust regrowth in peripheral
nerves, and in the central tracts of
young mammals and in adult
lower vertebrates, lend hope that
the constraints on regeneration
involve sufficiently few players
that pharmacological
interventions might be designed
that can stimulate injured tracts to
regenerate functionally.
Anatomy of the injury site
CNS axons are normally
surrounded by insulating layers of
lipids called myelin sheaths, made
by a type of cell called an
oligodendrocyte. After injury, the
severed tips of these neurons
encounter a varied terrain as they
attempt to regenerate, contacting
components present in the intact
CNS as well as those unique to
the injured CNS. Following
traumatic insult, the distal portion
of a severed axon will degenerate
and the resulting debris from it
and its surrounding myelin sheath
persists along the lengths of the
degenerated tracts until the
fragments are cleared by
macrophages as well as another
type of cell termed microglia. 
Although they share many
structural similarities, the PNS
environment differs from that of
the CNS. To begin with, PNS
axons are myelinated by Schwann
cells rather than
oligodendrocytes, glial cells that
are morphologically and
physiologically distinct from their
CNS myelinating counterparts.
CNS and PNS injury can also be
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Figure 1. In the adult vertebrate CNS very few, if any, axons regenerate past a lesion
site.
(A) In this sagittal view of an injured mouse spinal cord, where rostral is left and dorsal
is top, neurons that project from the brain to the spinal cord have been labeled with a
dye (black) that allows them to be visualized. Eight weeks after injury, axons remain
stalled out near the site of transection (red arrow). (B) A higher magnification image
shows characteristic retraction bulbs (arrowheads) at the tips of these axons.
distinguished by how quickly
degenerating tissue is eliminated.
The cleaning-up of axon
fragments and myelin debris is
many times more efficient in the
PNS than in the CNS, a feature
probably explained by the
involvement of different cellular
players as well as differential
access to the immune system.
The histology of a lesion varies
somewhat depending on the type
of injury sustained, but generally in
the CNS the epicenter is quickly
invaded by a host of cell types,
including fibroblasts, vascular
endothelial cells and
macrophages. Surrounding this
area is a zone of glial cells filled
with astrocytes, oligodendrocyte
precursors and microglia.
Astrocytes in this region become
markedly hypertrophic, and these
‘reactive astrocytes’ go on to form
a dense network called a glial
scar. This particular scarring
response is unique to the CNS, as
there are no astrocytes in the PNS.
In the field’s effort to define
what goes wrong after injury, the
neurons’ intrinsic growth state,
the glial scar, myelin debris, and
invading cells from the periphery
have all in turn been investigated
as likely suspects involved in
inhibiting CNS regeneration.
Barriers to regeneration
Embryonic and adult neurons differ
substantially in their intrinsic
growth potential, with their axons
switching perinatally from an
elongating to a more branching
phenotype. This shift in growth
ability led researchers to postulate
that the intrinsic growth state of
adult CNS neurons disfavors
regeneration [2]. Although
mammalian central neurons
generally do not regrow after
injury, particular situations have
been described which
‘precondition’ these cells for later
regenerative outgrowth. This
phenomenon has been
documented in a type of bipolar
sensory neurons, cells whose
peripheral, but not central, branch
normally regenerates after injury.
However, if the peripheral branch
is lesioned before the central
branch, the neuron is somehow
‘primed’ such that the central fiber
will now sprout some distance
after a CNS lesion, showing that
the central branch is indeed
capable of regeneration [3,4]. The
manipulation of signaling pathways
by elevating the level of cyclic
(c)AMP can similarly change a
neuron’s propensity to regenerate.
Indeed, CNS regeneration can be
enhanced in vivo by delivering a
cAMP analog or by administering
rolipram, which inhibits an enzyme
that blocks the breakdown of
cAMP [5].
Keeping in mind that intrinsic
factors play an important role,
classic experiments by Aguayo
and colleagues [6] argue that
environmental cues also ultimately
dictate whether or not an adult
neuron will regenerate after injury.
In a clever set of experiments
these researchers used segments
of PNS nerve to connect rats’
spinal cords with their brain
stems. Remarkably, they
observed that many CNS axons
grew out from the spinal cord
more than three centimeters into
this peripheral nerve graft. This
experiment was particularly
exciting because it showed that,
in a suitable environment, CNS
neurons are capable of extending
processes as adults. This
recognition galvanized efforts to
determine which molecular
differences between the PNS and
CNS environment makes the latter
inhospitable for the re-growth of
adult neurons. While the CNS may
lack certain positive factors
present in the PNS [7], much
attention has focused on
molecules present in the CNS that
actively block regeneration.
The glial scar
Several lines of evidence suggest
that the glial scar contributes to
regeneration block [8]. When
dissociated adult neurons were
injected into rats that had
sustained CNS injuries,
researchers observed that many
of these transplanted cells grew
considerable distances, hindered
only when they approach the glial
scar. The addition of growth
factors similarly increased the
ability of CNS axons to grow, but
they still stalled out at the scarred
region. After traumatic insult, a
number of extracellular molecules
of the chondroitin sulfate
proteoglycan (CSPG) family are
elevated in the scar tissue,
leading researchers to propose
these molecules as candidates for
mediating the inhibitory activity of
the scar. 
Consistent with this possibility,
the application of chondroitinase
ABC (chABC), an enzyme which
selectively degrades CSPGs,
leads to clear regeneration in vivo
following various types of CNS
lesion [8,9]. This negative effect of
CSPGs on regenerative outgrowth
may reflect a direct effect on the
axons. Alternatively, as these
highly charged molecules bind
many molecules, it is conceivable
that neurons are inhibited by
distinct factors that associate with
CSPGs. As chABC treatment has
been shown to be a robust and
reproducible method of increasing
CNS regeneration, this line of
research should prove exciting to
follow in coming years as the
molecular players are delineated.
Inhibitory proteins within CNS
myelin
As previously mentioned, the
clearance of myelin debris is
extremely slow within the adult
CNS. As these remnants persist
for weeks and months after injury,
the possibility was raised that
residual myelin contains factors
that actively prevent injured
neurons from regenerating.
Numerous in vitro experiments are
consistent with this hypothesis; for
example, dissociated neurons are
impeded from extending axons
when plated on either purified
myelin extracts or substrates of
myelin-rich CNS tissue [10,11].
Various approaches that target
myelin lead to some regeneration
in vivo; examples include
experiments where animals were
first irradiated in order to impair
the formation of myelin-producing
oligodendrocytes, or immunized
with myelin extracts [11].
Over the past decade three
prominent myelin-derived
inhibitors have been identified:
myelin associated glycoprotein
(MAG), Nogo-A, and
oligodendrocyte myelin
glycoprotein (OMgp) [12].
Surprisingly, although these three
inhibitors are structurally distinct,
work from the last several years
Magazine
R751
has suggested that all three bind
a receptor complex containing the
Nogo receptor (NgR), the low
affinity neurotrophin receptor
(p75NTR) and/or the p75NTR
relative TROY [13]. Signaling
through this receptor complex is
thought to inhibit neurite
outgrowth by activating RhoA and
ROCK, molecules known to
regulate cytoskeletal dynamics
[14]. Hopes remain high that this
striking convergence of inhibitory
signaling pathways may allow for
simultaneous targeting of multiple
inhibitory constituents of CNS
myelin.
Knockout mice for many of
these molecules, including Nogo,
MAG, NgR and p75NTR have been
generated, and mutant animals
have also been assessed for their
potential to regenerate after
injury. Although some lines
demonstrate evidence of
increased regeneration, the
absence of a robust regenerative
phenotype in others suggests
that redundancies in myelin cues
or synergy with other inhibitory
factors ultimately prevent
successful regrowth ([15,16] and
references therein). In general,
the relative contributions of each
of these individual factors to
regeneration block remains
unclear. Future analysis of
various double and triple
knockout animals should be
instructive.
Guidance molecules as
contributors to regeneration block 
Other factors that are strong
candidates for contributing to
regeneration block are members
of the netrin, semaphorin, ephrin
and slit families of axon guidance
molecules. Many of these proteins
instruct neurons’ directional
choices during embryonic
development through repulsive or
inhibitory actions on axons [17].
Aspects of successful
regeneration recapitulate
developmental events, and the
potent ability of some of these
molecules to repulse embryonic
axons underscores the possibility
that they inhibit regeneration in
the adult. Although many axon
guidance molecules are
downregulated when
development is complete, some of
them remain expressed in the
adult, and others are reexpressed
following injury in components of
the glial scar, in myelin, or in gray
matter [18,19]. 
The contributions of these
molecules to regeneration block
are only now starting to be
defined. In one recent study [20],
striking regeneration was
observed following spinal cord
injury in mice mutant for an ephrin
receptor, EphA4. Various
members of the semaphorin
family of molecules are highly
expressed after injury, and recent
in vitro work has shown that one
of these proteins, Sema5A, likely
contributes to the regeneration
block of neurons which project
from the retina to the brain
[18,21]. Many of these repulsive
axon guidance ligands and their
receptors are expressed in
patterns consistent with their
playing a role in the regeneration
block; in particular, netrin-1,
Sema4D and ephrinB3 have all
been shown to be expressed by
CNS myelin, and evidence has
been obtained that Sema4D and
ephrinB3 contribute to the
inhibitory activity of myelin in vitro
[19,22,23]. It will be important to
ascertain to what extent they
contribute to the observed stalling
out of axons after injury.
Conclusions
Despite the passage of forty-five
centuries since an anonymous
ancient Egyptian described the
catastrophic effects of CNS injury
[24] (Figure 2), it wasn’t until the
last 20 years that we have begun
to understand some of the
molecular events that contribute
to regeneration block. As
researchers continue to define
and characterize the critical
barriers to regeneration, it will be
interesting to assess to what
extent recovery is possible. Many
investigators have been
pondering and started to tackle
critical ‘next-step’ questions.
Once past the lesion site, do
regenerating fibers successfully
navigate back to their former
target cells? If so, do they form
functional synapses? Are
treatment strategies that repair a
clean knife-swipe (cut) lesion
pertinent to the complex
contusion (crush) injuries that
comprise the vast majority of
human cases? Will therapies be
limited to recent injuries, or might
people benefit who have
sustained spinal cord damage
years or even decades before?
This is clearly a time of great
excitement and hope — and a
belief that understanding the
molecular processes that prevent
regeneration could shift treatment
options from palliative care to
targeted restorative therapies.
Although it may prove difficult to
completely recover lost function,
successfully encouraging neurons
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Figure 2. The Edwin Smith surgical papyrus.
The earliest known reference to CNS injury is from an Egyptian text written about 2500
B.C. [24] “When you examine a man with a dislocation of a vertebra of his neck, and you
find him unable to move his arms, and his legs…Then you have to say: a disease one
cannot treat”. Courtesy of the New York Academy of Medicine Library.
to grow just a spinal segment or
two could translate into dramatic
quality-of-life improvements. For
instance, short-distance
restoration of spinal circuitry
could allow patients with cervical
injuries to breathe independently
without a respirator, or those who
have sustained lumbar injuries to
increase mobility and regain
bowel and bladder function. The
field of CNS regeneration is alive
and bursting with potential; the
next decade holds the promise of
exciting progress.
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Requirement for
high-level
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We are constantly learning new
things as we go about our lives,
and refining our sensory abilities.
How and when these sensory
modifications take place is the
focus of intense study and we
report here that even subliminal
learning, which occurs without
awareness of what is learned,
requires high-level processing.
Some researchers have
proposed that sensory plasticity
can only take place on features a
person attends to [1,2], but others
have shown sensory
improvements can occur for
unattended features [3,4]. In the
latter case, subliminal motion
vectors were learned when they
were temporally correlated with
the targets of the subject’s task
[3]. This led to the view that
successful recognition of the task-
targets triggers a diffuse learning
signal that enables learning of
features temporally correlated
with the task-targets. We have
directly tested this proposition to
ascertain what level of processing
is required for this subliminal
learning.
We used the attentional blink
paradigm [5]: an imbalance in
identification accuracy of two
masked targets presented in rapid
succession; the first target is seen
but the second not. The
attentional blink is mostly studied
within the context of a rapid serial
visual presentation (RSVP). For
example, in our experiment,
participants were trained on the
identification of two target digits
(T1, T2) presented within a series
of distractor letters (Figure 1).
Each stimulus is presented for
100 ms, and subjects must hold
